Anticancer compounds
US-12162870-B2 · Dec 10, 2024 · US
with substituted hydrocarbon radicals attached to ring nitrogen atoms
with substituted hydrocarbon radicals attached to ring nitrogen atoms · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07D295/04 |
| Official title | with substituted hydrocarbon radicals attached to ring nitrogen atoms |
| Display label | with substituted hydrocarbon radicals attached to ring nitrogen atoms |
| Total patents | 64 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is rapidly declining.
| Year | Patents |
|---|---|
| 2015 | 11 |
| 2016 | 5 |
| 2017 | 4 |
| 2018 | 6 |
| 2019 | 7 |
| 2020 | 8 |
| 2021 | 7 |
| 2022 | 3 |
| 2023 | 5 |
| 2024 | 5 |
| 2025 | 2 |
| 2026 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Substituted amide compounds useful as farnesoid X receptor modulators
US-12030835-B2 · Jul 9, 2024 · US
Amyloid targeting agents and methods of using the same
US-2024208916-A1 · Jun 27, 2024 · US
Melanocortin subtype-2 receptor (mc2r) antagonists and uses thereof
US-2024109866-A1 · Apr 4, 2024 · US
Activator of TREK (TWIK RElated K+channels) channels
US-11851428-B2 · Dec 26, 2023 · US
2,3-dihydro-1h-imidazo{1,2-a}pyrimidin-5-one and this 1,2,3,4-tetrahydropyrimido{1,2-a}pyrimidin-6-one derivatives comprising a substituted morpholine, preparation thereof and pharmaceutical use thereof
US-11739100-B2 · Aug 29, 2023 · US
Amyloid targeting agents and methods of using the same
US-11718596-B2 · Aug 8, 2023 · US
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
US-11566015-B2 · Jan 31, 2023 · US
Anticancer compounds
US-2023025178-A1 · Jan 26, 2023 · US
Aziridinyl and amino dimeric naphthoquinone compounds and use for acute myeloid leukemia
US-11459313-B2 · Oct 4, 2022 · US
Substituted amide compounds useful as farnesoid x receptor modulators
US-2022213026-A1 · Jul 7, 2022 · US
Therapeutics targeting mutant adenomatous polyposis coli (apc) for the treatment of cancer
US-2022024891-A1 · Jan 27, 2022 · US
Amyloid targeting agents and methods of using the same
US-2021371390-A1 · Dec 2, 2021 · US
Activator of trek (twik related k+ channels) channels
US-2021347773-A1 · Nov 11, 2021 · US
Melanocortin subtype-2 receptor (mc2r) antagonists and uses thereof
US-2021238164-A1 · Aug 5, 2021 · US
Activator of TREK (TWIK RElated K+ channels) channels
US-11046683-B2 · Jun 29, 2021 · US
Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof
US-10981894-B2 · Apr 20, 2021 · US
Amyloid targeting agents and methods of using the same
US-10934264-B2 · Mar 2, 2021 · US
Melanocortin subtype-2 receptor (mc2r) antagonists and uses thereof
US-2021002254-A1 · Jan 7, 2021 · US
Aziridinyl and amino dimeric naphthoquinone compounds and use for acute myeloid leukemia
US-2020283417-A1 · Sep 10, 2020 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07D295/04?
- CPC C07D295/04 is the Cooperative Patent Classification code for “with substituted hydrocarbon radicals attached to ring nitrogen atoms.”
- How many patents are filed under CPC C07D295/04 (with substituted hydrocarbon radicals attached to ring nitrogen atoms)?
- Our database includes 64 publications tagged with this CPC code.
- Is patent activity under CPC C07D295/04 growing?
- Publication counts under this code: 5 in 2024 vs 2 in 2025 (latest complete years).